Oncology Nursing News
Panelists discuss how amivantamab’s dual targeting of EGFR and MET may address resistance mechanisms and unmet needs in EGFR-mutated advanced non–small cell lung cancer (NSCLC), with Dr Scott highlighting its potential clinical benefits, while Squires shares insights on managing the adverse event profile and strategies for managing adverse effects in patients receiving intravenous (IV ...
Adding Chemo to Osimertinib Improves Survival After Progression …
Apr 5, 2024 · Patients with EGFR-mutated advanced non–small cell lung cancer (NSCLC) treated with firstline osimertinib (Tagrisso) plus platinum-pemetrexed chemotherapy demonstrated long-term, clinically meaningful, and statistically significant survival outcomes after disease progression compared with osimertinib alone, according to a prespecified analysis of post-progression outcomes and updated ...
Understanding the Role of an Oncology Research Nurse
Sep 26, 2024 · Oncology research nurses play an integral role in collecting data and assessing for adverse events throughout a clinical trial, which, in turn, can lead to their support in the development of new cancer therapies.
Alectinib Reduces Risk of Recurrence or Death by 76% in Early …
Oct 21, 2023 · Alectinib (Alecensa), an oral ALK inhibitor, significantly improved disease-free survival (DFS) among patients with resected ALK-positive non–small-cell lung cancer (NSCLC), according to data from the phase 3 ALINA trial (NCT0345076). 1. The findings, which were presented at the 2023 ESMO conference, showed that the targeted therapy elicited superior outcomes than platinum-based chemotherapy ...
Shift in Nurse-Led Mindset Helps Quell Fear of Cancer Recurrence
Oct 29, 2024 · An intervention focusing on techniques to better focus patients’ attention may be beneficial in improving fear of cancer recurrence, according to recent research presented at the 21st International Conference of the Society for Integrative Oncology. 1 In a recent interview, study author Anne M. Reb, PhD, NP, discusses her abstract on a nurse-led videoconferencing intervention for patients ...
20 Inspirational Quotes for Cancer Survivors, Fighters, and Caregivers
Aug 25, 2015 · The FDA has granted approval for the use of encorafenib in combination with cetuximab and mFOLFOX6 for the treatment of metastatic colorectal cancer harboring a BRAF V600E mutation.
Tailoring Second-Line Treatments for HR-Positive, HER2-Negative ...
Jul 11, 2024 · The dynamic landscape of second-line treatments for patients with HR-positive, HER2-negative metastatic breast cancer presents both opportunities and challenges for oncology nurses and APPs, highlighting the importance of staying informed about the latest advancements, understanding the limitations of current therapies, and proactively managing patient care.
New Management Strategies Seek to Improve Quality of Life for …
Nov 20, 2023 · In an interview with Oncology Nursing News after their presentation, they talked about which patients are at risk for lymphedema, as well as how new treatment strategies aim to improve the quality of care that nurses can provide for these individuals.. Which Patients Are At Risk? Lymphedema affects a lot of patients with cancer, said Taylor and Lin, and not just patients with breast cancer.
Neoadjuvant, Adjuvant Nivolumab Improve EFS in Resectable NSCLC
Oct 21, 2023 · Neoadjuvant treatment with nivolumab (Opdivo) plus chemotherapy followed by surgery and adjuvant nivolumab significantly improved event-free survival (EFS), compared with placebo plus chemotherapy, in patients with previously untreated resectable stage II to IIIB non-small cell lung cancer (NSCLC), according to data from the phase 3 CheckMate 77T trial (NCT04025879) presented at ESMO Congress ...
The Role of Advanced Practice Nursing in Palliative Care
Mar 27, 2014 · Katherine Yeager, PhD, RN. Research Assistant Professor. With the aging of the US population, the number of seriously ill patients with complex conditions is expected to rise.